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INTRODUCTION
Antiphospholipid antibodies such as anticardiolipin anti-
body and lupus anticoagulant are polyclonal and polyclass
antibodies directed against certain phospholipids, and are
known to be associated with a hypercoagulable state (1). If a
patient with antiphospholipid antibodies develops one of
the clinical manifestations of venous or arterial thrombosis,
thrombocytopenia, or recurrent miscarriage, the patient can
be diagnosed as an antiphospholipid antibody syndrome
(APAS). When there are no other underlying diseases such
as systemic lupus erythematosus (SLE), it is classified as pri-
mary APAS. Sometimes the spontaneous abortion can be
unnoticed to the patient, and she may erroneously regard
herself as infertile. Whether a patient has just antibodies or
APAS, the patient with antiphospholipid antibodies can be
a candidate of assisted reproduction treatment such as in vitro
fertilization (IVF), which harbors a chance of developing an
ovarian hyperstimulation syndrome (OHSS), the most fear-
ful complication of ovulation induction.
OHSS is an iatrogenic, potentially lethal complication dur-
ing ovulation induction (2). The pathophysiologic hallmark
is a massive accumulation of extravascular exudates combined
with a profound intravascular volume depletion and hemo-
concentration. Its clinical manifestations are diverse from mild
edema and oliguria to electrolyte imbalance, massive ovari-
an enlargement, tense ascites and pleural effusion, renal fail-
ure, and thromboembolic events. Thus if OHSS develops in
a hypercoagulable state like APAS, the thrombotic potential
will be synergistically enhanced, making a vicious cycle and
resulting in serious thromboembolic complications. We de-
scribe a case of OHSS complicated by a cerebral infarct in a
patient with APAS. 
CASE REPORT
A 33-yr-old woman was admitted to a local infertility clinic
due to mild dyspnea and progressive abdominal distention.
She had been on the course of ovulation induction during
IVF, and the embryo transfer was done 11 days before admis-
sion. Under an impression of OHSS, she was conservatively
treated with balancing fluid and electrolytes and paracente-
sis with some improvement. Three days after admission, she
suddenly developed left hemiparesis and dysarthria, and was
transferred to the emergency room of our hospital. She had
a past obstetrical history of pregnancy via IVF one year before,
which resulted in a spontaneous abortion. At that time, she
also experienced mild OHSS and hypertension, which was
treated by oral antihypertensive medication.
At the emergency room, her blood pressure was 140/110
mmHg and pulse rate was 110 beats per minute. Physical
examination revealed a distended abdomen with ascites. On
neurologic examination, she showed mild disorientation, dys-
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A Case of Cerebral Infarct in Combined Antiphospholipid Antibody
and Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome is a serious complication of ovulation induc-
tion and has a diverse clinical spectrum from edema to thromboembolism. Anti-
phospholipid antibody syndrome, one of the well known hypercoagulable states,
can be also manifested as an arterial or venous thrombosis and recurrent spon-
taneous abortion. Sometimes a patient with antiphospholipid antibodies might not
notice a miscarriage and seek for assisted reproduction treatment, which harbors
a chance of developing ovarian hyperstimulation syndrome. If this happens, the
ovarian hyperstimulation syndrome can exacerbate the thrombotic complication
of underlying antiphospholipid antibody syndrome, resulting in a catastrophic vas-
cular event. The authors experienced a case of middle cerebral artery infarct, which
developed during ovarian hyperstimulation syndrome in a 33-yr-old woman with
a previous history of fetal loss. An elevated titer of anticardiolipin antibodies was
noticed and persisted thereafter. The authors suggest screening tests for the pres-
ence of antiphospholipid antibodies before controlled ovarian hyperstimulation. 
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Accepted : 24 September 2001arthria, left facial palsy, left visual field defect, and right gaze
preponderance. Left-sided hemiparesis, hypesthesia, and hemi-
neglect were also detected. The left hemiparesis later pro-
gressed to a complete hemiplegia. With an impression of acute
right supratentorial stroke, brain magnetic resonance image
(MRI) and angiography (MRA) were done. Brain MRI showed
a bright high signal intensity in the right middle cerebral
artery (MCA) territory on diffusion-weighted image, suggest-
ing an acute MCA infarct (Fig. 1). MRA demonstrated an
occlusion of the right MCA (Fig. 2). Etiologic workup for the
young age stroke, including laboratory tests for hypercoagula-
ble state were performed. On complete blood counts, WBC
was elevated (14,500/ L), and hemoglobin (10.4 g/ dL) and
hematocrit (32.4%) were slightly decreased. Platelet counts
were normal (235,000/ L). Mild hyponatremia (130 mEq/L)
was detected. On coagulation profile, her prothrombin time
was 13.5 sec, activated partial prothrombin time was 22.1 sec,
both in normal ranges. However, a decreased level of protein
S and elevated anticardiolipin Ig M level were noticed and
persisted thereafter (Table 1). Transthoracic echocardiography
did not find any cardiac abnormalities. Abdominal ultra-
sonography showed ascitic fluid in the pelvis and bilaterally
enlarged ovaries with multiple follicles. A test for pregnan-
cy was positive. Her neurologic status was stabilized after a
few days but her symptoms of OHSS, such as abdominal pain
and dyspnea, worsened despite supportive treatment. The
pregnancy was terminated by dilatation and curettage on
the 16th hospital day. After termination, her general condi-
tion recovered within a few days and a physical therapy was
started. After 3 month, the left-sided weakness improved
significantly and she could walk with an assisting device by
herself.
DISCUSSION
Thromboembolism is a rare but serious complication of
OHSS, most of which is venous in origin from the lower ex-
tremities (3), and there has been few reports of cerebral infarct
complicating OHSS in the literature (4-6). In part of these
cases, the laboratory tests for the hypercoagulable state includ-
ing antiphospholipid antibody were performed, but there has
been no case with positive results. Despite the rarity of the
reported cases, we think that ischemic stroke in combined
OHSS and APAS like our case can occur, because a patient
with APAS might miss the spontaneous abortion and seek
for the management of infertility, as previously mentioned.
The exact cause of thromboembolism in OHSS is still not
completely understood. An induced secondary hypercoagu-
lable state due to the hemoconcentration has been suggested
(3). However in our case, the initial hematocrit and hemo-
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Fig. 1. Brain magnetic resonance diffusion weighted image show-
ing an acute right middle cerebral artery infarct.
Fig. 2. Brain magnetic resonance angiography demonstrating a
right middle cerebral artery occlusion.
Anticardiolipin Ig M 16.1 12.7 46.2 <12.5 MPL
�
Anticardiolipin Ig G Negative Negative - <20.0 GPL
�
Lupus anticoagulant Negative -- -
Protein C 135 120 - 70-140%
Protein S 43 63 62 71-103%
Antithrombin III 100 -- 80-120%
Table 1. Summary of patient's coagulation laboratory findings
On Admission 1 Month 2 Months Normal Range
* - : not performed,  
� MPL: Ig M phospholipid unit, 
� GPL: Ig G phospho-
lipid unit.globin levels were decreased, against for the hemoconcentra-
tion. The decreased levels of hemoglobin and hematocrit are
partly due to the effect of hemodiluting treatment for OHSS
at the infertility clinic. However, as there has been some re-
ports of OHSS that developed thromboembolism without
the evidence of hemoconcentration (5), it is possible that the
hemoconcentration may not be the sole underlying mecha-
nism of the thromboembolism, at least in some cases includ-
ing ours.
The activation of hemostatic system is another possible ex-
planation of the thromboembolism in OHSS (7). Decreased
levels of antithrombin III and prekallikrein are frequently
detected in OHSS, and the time course is also consistent with
the thromboembolic complication (8). A growing body of
evidences indicate that the activation of hemostasis and plasma
kinin system are the underlying pathogenesis of thrombo-
embolism in OHSS, though what triggers the activation is
still obscure.
In our case, a decreased level of protein S was detected. Al-
though the protein S level can be decreased by the pregnancy
itself, in our case the decreased level of protein S persisted
after the termination of the pregnancy. So despite the rela-
tively small decrease, we could not rule out the possibility
that the decreased level of the protein S contributed to the
development of thromboembolism in this case. On the other
hand, the Ig M anticardiolipin antibody titer was highly and
persistently elevated. With the history of spontaneous abor-
tion and cerebral infarct, the diagnosis of APAS could be easi-
ly made. Although APAS itself can cause cerebral infarct, in
this case the ischemic stroke developed in the middle of OHSS.
Since OHSS itself has a thromboembolic potential, the au-
thors think that there must have been a synergistic effect.
Natural pregnancy is nowadays allowed in a majority of
SLE patients. However, regarding the consequences of assist-
ed reproduction treatment in the SLE or primary APAS pa-
tients, only little information is available (9). Huong et al.
tried ovulation induction in four SLE patients, but failed in
all, while one developed venous thrombosis (10). Recently,
Guballa et al. retrospectively analysed 68 cycles of ovulation
induction/IVF in 19 SLE and primary APAS patients (11),
in whom prophylactic treatment with heparin or aspirin was
used. Even though the pregnancy was possible, the overall
outcome was poor due to the high rate of fetal and maternal
complications. Thrombotic events were not noticed in this
series. From our experience and these reports, the authors re-
commend the screening test for the antiphospholipid anti-
bodies before ovulation induction, because there may be a
risk of fetal and maternal complications including cerebrovas-
cular accidents. Prophylactic treatment with antiplatelet agents
or anticoagulants are possible preventive measures against
thrombotic complications.
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